Annual CFF
-$4.22 M
-$4.95 M-679.56%
December 31, 2023
Summary
- As of February 7, 2025, INMB annual cash flow from financing activities is -$4.22 million, with the most recent change of -$4.95 million (-679.56%) on December 31, 2023.
- During the last 3 years, INMB annual CFF has fallen by -$28.12 million (-117.68%).
- INMB annual CFF is now -104.38% below its all-time high of $96.36 million, reached on December 31, 2021.
Performance
INMB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$9.79 M
-$3.21 M-24.66%
September 30, 2024
Summary
- As of February 7, 2025, INMB quarterly cash flow from financing activities is $9.79 million, with the most recent change of -$3.21 million (-24.66%) on September 30, 2024.
- Over the past year, INMB quarterly CFF has dropped by -$3.21 million (-24.66%).
- INMB quarterly CFF is now -81.50% below its all-time high of $52.94 million, reached on September 30, 2021.
Performance
INMB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$17.79 M
+$11.52 M+183.63%
September 30, 2024
Summary
- As of February 7, 2025, INMB TTM cash flow from financing activities is $17.79 million, with the most recent change of +$11.52 million (+183.63%) on September 30, 2024.
- Over the past year, INMB TTM CFF has increased by +$11.52 million (+183.63%).
- INMB TTM CFF is now -81.54% below its all-time high of $96.36 million, reached on September 30, 2021.
Performance
INMB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
INMB Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -679.6% | -24.7% | +183.6% |
| 3 y3 years | -117.7% | -24.7% | +183.6% |
| 5 y5 years | -569.4% | -24.7% | +183.6% |
INMB Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -104.4% | at low | -24.7% | +491.7% | -81.5% | +364.5% |
| 5 y | 5-year | -104.4% | at low | -81.5% | +491.7% | -81.5% | +364.5% |
| alltime | all time | -104.4% | at low | -81.5% | +491.7% | -81.5% | +364.5% |
INmune Bio Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $9.79 M(-24.7%) | $17.79 M(+183.6%) |
| Jun 2024 | - | $13.00 M(-619.9%) | $6.27 M(-193.3%) |
| Mar 2024 | - | -$2.50 M(0.0%) | -$6.72 M(+59.2%) |
| Dec 2023 | -$4.22 M(-679.6%) | -$2.50 M(+44.9%) | -$4.22 M(+144.9%) |
| Sep 2023 | - | -$1.73 M(<-9900.0%) | -$1.73 M(<-9900.0%) |
| Jun 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2022 | $729.00 K(-99.2%) | $0.00(0.0%) | $729.00 K(0.0%) |
| Sep 2022 | - | $0.00(0.0%) | $729.00 K(-98.6%) |
| Jun 2022 | - | $0.00(-100.0%) | $53.67 M(-21.8%) |
| Mar 2022 | - | $729.00 K(>+9900.0%) | $68.62 M(-28.8%) |
| Dec 2021 | $96.36 M | $0.00(-100.0%) | $96.36 M(0.0%) |
| Sep 2021 | - | $52.94 M(+254.1%) | $96.36 M(+44.6%) |
| Jun 2021 | - | $14.95 M(-47.5%) | $66.66 M(+27.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $28.46 M(>+9900.0%) | $52.37 M(+119.2%) |
| Dec 2020 | $23.89 M(+95.7%) | $0.00(-100.0%) | $23.89 M(0.0%) |
| Sep 2020 | - | $23.24 M(+3400.0%) | $23.89 M(+3548.1%) |
| Jun 2020 | - | $664.00 K(-7477.8%) | $655.00 K(-86.8%) |
| Mar 2020 | - | -$9000.00(<-9900.0%) | $4.95 M(-59.5%) |
| Dec 2019 | $12.21 M(+1256.6%) | $0.00(0.0%) | $12.21 M(0.0%) |
| Sep 2019 | - | $0.00(-100.0%) | $12.21 M(0.0%) |
| Jun 2019 | - | $4.96 M(-31.6%) | $12.21 M(+68.4%) |
| Mar 2019 | - | $7.25 M(>+9900.0%) | $7.25 M(+705.7%) |
| Dec 2018 | $900.00 K(-56.2%) | $0.00(0.0%) | $900.00 K(0.0%) |
| Sep 2018 | - | $0.00(0.0%) | $900.00 K(0.0%) |
| Jun 2018 | - | $0.00(-100.0%) | $900.00 K(0.0%) |
| Mar 2018 | - | $900.00 K | $900.00 K |
| Dec 2017 | $2.06 M(+356.9%) | - | - |
| Dec 2016 | $450.00 K | - | - |
FAQ
- What is INmune Bio annual cash flow from financing activities?
- What is the all time high annual CFF for INmune Bio?
- What is INmune Bio annual CFF year-on-year change?
- What is INmune Bio quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for INmune Bio?
- What is INmune Bio quarterly CFF year-on-year change?
- What is INmune Bio TTM cash flow from financing activities?
- What is the all time high TTM CFF for INmune Bio?
- What is INmune Bio TTM CFF year-on-year change?
What is INmune Bio annual cash flow from financing activities?
The current annual CFF of INMB is -$4.22 M
What is the all time high annual CFF for INmune Bio?
INmune Bio all-time high annual cash flow from financing activities is $96.36 M
What is INmune Bio annual CFF year-on-year change?
Over the past year, INMB annual cash flow from financing activities has changed by -$4.95 M (-679.56%)
What is INmune Bio quarterly cash flow from financing activities?
The current quarterly CFF of INMB is $9.79 M
What is the all time high quarterly CFF for INmune Bio?
INmune Bio all-time high quarterly cash flow from financing activities is $52.94 M
What is INmune Bio quarterly CFF year-on-year change?
Over the past year, INMB quarterly cash flow from financing activities has changed by -$3.21 M (-24.66%)
What is INmune Bio TTM cash flow from financing activities?
The current TTM CFF of INMB is $17.79 M
What is the all time high TTM CFF for INmune Bio?
INmune Bio all-time high TTM cash flow from financing activities is $96.36 M
What is INmune Bio TTM CFF year-on-year change?
Over the past year, INMB TTM cash flow from financing activities has changed by +$11.52 M (+183.63%)